Healthcare Medical Device Outsourcing Services sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Healthcare Medical Device Outsourcing Services
1.1 - About Healthcare Medical Device Outsourcing Services sector
Companies in this category provide end-to-end outsourced engineering and manufacturing for regulated medical devices. Through Healthcare Medical Device Outsourcing Services, they design, prototype, and produce components and finished devices under ISO 13485 quality systems, integrating supply chain, compliance, and validation support. Their value proposition centers on faster commercialization, lower unit costs, and reliable scalability for OEMs and innovators needing compliant production without expanding internal footprint.
These providers deliver contract design and human-factors engineering, rapid prototyping, DFM/DFA, and tooling. They run cleanroom molding and precision machining, electronics and sensor integration, catheter and disposables assembly, and sterile barrier packaging. Services typically include biocompatibility and reliability testing, sterilization process validation, quality management and traceability, regulatory dossiers and 510(k) support, and global supply chain planning for volume ramp and lifecycle maintenance.
Primary customers include medical device OEMs, medtech startups, and diagnostics firms seeking external capacity and regulatory expertise. Outcomes delivered are accelerated time-to-market through concurrent engineering, reduced capex and cost per unit via scalable manufacturing, improved compliance and audit readiness, and risk mitigation across materials, sterilization, and supplier management. These partners help strategic buyers in medical device outsourcing achieve predictable launches and flexible capacity.
2. Buyers in the Healthcare Medical Device Outsourcing Services sector
2.1 Top strategic acquirers of Healthcare Medical Device Outsourcing Services companies
Kimball Electronics
HQ: United States
Website
- Description: Provider of Electronics Manufacturing Services (EMS), contract manufacturing, and engineering & design solutions for medical, industrial, and automotive sectors, leveraging a global network of facilities across North America, Europe and Asia to enhance customers’ product quality, health, safety, productivity and comfort.
- Key Products:
- Electronics Manufacturing Services (EMS): End-to-end assembly of electronic products, including circuit board population, testing and quality assurance, supporting medical, industrial and automotive applications with Industry 4.0 practices
- Contract Manufacturing Organization (CMO): Provides full-scale outsourcing of product fabrication, procurement, assembly and logistics, allowing customers to focus on core competencies while ensuring consistent, high-quality output
- Engineering & Design Services: Offers product design, engineering support and prototyping to transform concepts into manufacturable solutions that improve users’ health, safety and productivity
- Global Manufacturing Network: Operates facilities in the US
- Mexico
- Netherlands
- Poland
- Romania
- China and Thailand, giving customers regional production options, supply-chain flexibility and faster time-to-market.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Healthcare Medical Device Outsourcing Services sector
M&A buyer group 1: Manufacturing Services
171 companies
View group →
Description: Companies in the Industrial Contract Manufacturing Services category provide end‑to‑end outsourced production, engineering, and supply-chain execution for complex industrial and electronic products. They translate customer designs into manufacturable solutions, scale through automated plants, and manage compliant global sourcing, testing, and logistics to deliver high-quality assemblies and systems, improving time-to-market, cost efficiency, and reliability across regulated industrial sectors.
ITT
- Type: N/A
- Employees: ●●●●●
- Description: Provider of highly engineered components and customized technological solutions—such as pumps, valves, brake pads, shock absorbers and harsh-environment connectors—serving energy, transportation and industrial markets in more than 125 countries.
- Key Products:
- Industrial Pumps & Valves: Engineered pumps, valves, monitoring and control systems plus aftermarket services handle corrosive fluids in chemical, oil & gas, mining, pulp & paper, power and biopharma plants, boosting process reliability
- Brake Pads & Damping Solutions: High-quality, long-lasting brake pads, shock absorbers and damping technologies reduce wear and enhance safety for automotive and rail vehicles
- Harsh-Environment Connectors: Rugged electrical connectors maintain secure power and signal transmission in extreme aerospace, defense and industrial conditions, resisting vibration, temperature and contaminants
- Energy Absorption & Flow-Control Components: Critical motion-control and fluid-management parts absorb impact and regulate flow in aerospace, defense and industrial equipment, improving durability and performance.
🔒
🔒
🔒
View all 171 companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms in Healthcare Medical Device Outsourcing Services sector
3.1 - Buyout funds in the Healthcare Medical Device Outsourcing Services sector
2.2 - Strategic buyer groups for Healthcare Medical Device Outsourcing Services sector
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Healthcare Medical Device Outsourcing Services companies
4.2 - Public trading comparable groups for Healthcare Medical Device Outsourcing Services sector
Valuation benchmark group 1: Small Molecule CDMO Companies
13 companies
View group →
Description: Companies in this group are public contract development and manufacturing organizations focused on small‑molecule drug substances and related services. They generate revenue from fee‑for‑service research, CMC development, and multi‑year GMP supply agreements for APIs and intermediates, with select drug‑product and compounding capabilities. They are grouped as trading comparables given shared outsourcing models, regulatory track records, global manufacturing footprints, and exposure to innovator and generic pipelines.
Lonza Group
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of comprehensive services and products focusing on the discovery, development, and manufacturing of active pharmaceutical ingredients, biologics, and innovative dosage forms for the pharmaceutical, biotech, and consumer health industries to support the commercialization of various therapies, with a strong commitment to sustainability and zero-incident workplace initiatives.
- Key Products:
- Bioscience Products: Tools and technologies for cell culture, research, and quality control in biomanufacturing
- Capsule Manufacturing: Pharmaceutical services ensuring high-quality capsule products using gelatin, HPMC, or pullulan
- Biologics Manufacturing: Custom development and manufacturing services for biologics from late phase drug discovery to market supply
- API Development: Early phase discovery and manufacturing of active pharmaceutical ingredients for various therapeutic areas
- Healthcare Solutions: Innovative dosage forms and customized solutions for the pharma and consumer health industries.
🔒
🔒
🔒
View all 13 companies in this group
Request Free Trial Now →
🔒
Revenue growth
Median
15.7%
2025E
16.0%
2026E
EBITDA margin
Median
28.2%
2025E
28.6%
2026E
Cash EBITDA margin
Median
27.6%
2025E
28.0%
2026E
EV/Revenue
Median
8.4x
2025E
6.8x
2026E
EV/EBITDA
Median
28.9x
2025E
24.4x
2026E
EV/Cash EBITDA
Median
29.0x
2025E
25.5x
2026E
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →